Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001053558 | SCV001217826 | uncertain significance | Dyskeratosis congenita | 2019-03-22 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs368344044, ExAC 0.005%). This variant has not been reported in the literature in individuals with CTC1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces proline with leucine at codon 998 of the CTC1 protein (p.Pro998Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. |
Ambry Genetics | RCV004031687 | SCV004850981 | uncertain significance | Inborn genetic diseases | 2023-10-10 | criteria provided, single submitter | clinical testing | The c.2993C>T (p.P998L) alteration is located in exon 18 (coding exon 18) of the CTC1 gene. This alteration results from a C to T substitution at nucleotide position 2993, causing the proline (P) at amino acid position 998 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |